HAYAT PLASMA
CENTER
YOUR PLASMA,
THEIR LIFELINE
HAYAT PLASMA
CENTER
YOUR PLASMA,
THEIR LIFELINE
HAYAT PLASMA
CENTER
YOUR PLASMA,
THEIR LIFELINE
HAYAT PLASMA
CENTER
YOUR PLASMA,
THEIR LIFELINE
HAYAT PLASMA
CENTER
YOUR PLASMA,
THEIR LIFELINE
OUR MISSION
To revolutionize healthcare in the Middle East by pioneering innovative plasma donation
systems, creating a sustainable local supply for life-saving treatments and
groundbreaking research.
Key Objectives
Establish Saudi Arabia's first modern plasma
donation network
Empower donors to contribute directly to life-
saving treatments
Bridge the gap between donors and critical
medical research
Become the leading ethical plasma provider in
the MENA region
MEET THE TEAM
Hassan Shah Muadh Kaidali
Founder & CEO
Co-Founder & President
PROBLEM
STATEMENT
The Challenge
Saudi Arabia heavily relies on imported plasma and plasma-derived products (Most
countries in the MENA region, including Saudi Arabia, are heavily dependent on imported
plasma-derived medicinal products (PDMPs) (Source: WHO Eastern Mediterranean Regional
Office, 2019)"
Limited local plasma collection infrastructure
Growing demand for plasma-derived medications in the region
Why It Matters
Dependence on imports creates supply chain vulnerabilities
Increased healthcare costs due to importation
Missed opportunity for local job creation and economic growth
Potential shortages during global supply disruptions
MARKET OPPORTUNITY
Global Plasma Market Growth CAGR Projections
60
$48.5
50
billion
40
30 7.10%
$26.2 billion 7.50%
20
10
0
global plasma proteins market Middle East and Africa
2021 2031
Market Value
Key Opportunity in Saudi Arabia:
• Saudi healthcare expenditure projected to
grow from $36.4 billion in 2018 to $160
billion by 2030."
• Kingdom aims to increase private sector
contribution from 40% to 65% by 2030
(Source: Saudi Vision 2030)."
OUR SOLUTION
1 2 3 4
Establish state-of- Implement rigorous Utilize advanced Ensure high-quality
the-art plasma donor screening and plasmapheresis plasma storage
collection centers plasma testing technology for and handling
in Riyadh processes efficient collection
PLASMA POWER: SAVING
LIVES, ADVANCING
MEDICINE
Life-Saving Potential Essential Medical Applications
One Donation, Three Lives saved Immune deficiencies: Vital for immune deficiencies.
Plasma Storage Duration: Up to 1 Year for Hemophilia management better management.
Reliable Emergency Supply Critical Care: used in trauma, burns and surgeries
Blood Disorders Therapies: Essential for treatment.
Innovation in Emerging
Driving Medical Breakthroughs
Treatments
COVID-19: Used in severe cases. New Therapies: Plasma is central to
Alzheimer's: Potential treatment options. innovations.
Genetic Disorders: Exploring new therapies. Research: Fuels life-saving discoveries.
Growing Demand in Saudi
Arabia
Increasing need for plasma-derived medications in the Kingdom
Opportunity to educe dependence on international plasma
Establish local, sustainable plasma supply
Become regional leaders in plasma donation and processing
BUSINESS MODEL
Donor Recruitment and Retention
01.
Plasma Collection
02.
Processing and Quality Control
03.
04. Storage and Distribution
05. Sales to Pharmaceutical and Biotech Companies
DONATION AND PROCESSING
WORKFLOW
2. Plasmapheresis (1-2 hours) 4. Testing 6. Quality Control
Blood collection
Comprehensive pathogen Regular checks on storage conditions
Plasma separation via centrifugation
screening Thorough documentation of entire process
Return of red blood cells to donor
1. Donor Screening 3. Initial Processing 5. Freezing and Storage 7. Final Product: High-
Health screening (HIV, hepatitis,
Quality Frozen Plasma
etc.) Plasma collected and Frozen within 24 hours of Ready for distribution to pharmaceutical
Donor compensation explained prepared for testing collection and biotech companies
(based on local regulations and Stored at -20°C or colder
industry standards)
MARKET AND
SALES STRATEGY
Target Customers Pricing Strategy Sales Approach
Pharmaceutical companies Competitive pricing based on Direct contracts with pharma and
Biotech firms quality, volume, and contracts biotech companies
Fractionation facilities Determined through market Potential partnerships with global
analysis and buyer negotiations plasma suppliers
Focus on long-term relationships
COMPETITIVE ADVANTAGE
First-Mover in Saudi Alignment with Saudi
Plasma Collection Vision 2030
Strategic
Strategic
Location in Partnerships
Riyadh
Cultural Competence Scalable Business
Model
COMPETITIVE ADVANTAGE
First-Mover in Saudi Plasma Collection Alignment with Saudi Vision 2030
Pioneering the plasma collection industry in the Kingdom Reducing dependence on imported plasma products
Setting industry standards and best practices Creating high-skilled jobs in biotechnology sector
Early relationships with key stakeholders Contributing to national self-reliance in healthcare
Strategic Location in Riyadh Strategic Partnerships
Access to a large, diverse potential donor population Collaboration with Alfaisal University
Proximity to major healthcare and research institutions Access to medical expertise and research opportunities
Excellent infrastructure for logistics and distribution
Cultural Competence Scalable Business Model
Deep understanding of local cultural norms Designed for expansion across Saudi Arabia and GCC
Customized donor strategies for Saudi market Potential to become regional leader in plasma collection
MILESTONES
Achieved Next 12 Months Future Goals
Partnership established with Alfaisal University Q3 2024: Complete construction and equipping Year 2: Expand to 3 collection centers across Saudi Arabia
Regulatory approvals initiated for plasma of first collection center Year 3: Achieve 100,000 liters annual plasma collection
collection operations Q4 2024: Obtain final regulatory approvals Year 5: Establish presence in 2 additional GCC countries
Site secured in Riyadh for first collection center Q1 2025: Launch donor recruitment campaign
Q2 2025: Begin plasma collection operations
FUNDING REQUIREMENTS
01 How much capital are you seeking?
02 How will the funds be used?"
YOUR PLASMA,
THEIR LIFELINE
PUT YOUR TEXT HERE
PUT YOUR TEXT HERE
PUT YOUR TEXT HERE
PUT YOUR TEXT HERE
Comprehensive Financial Overview
Financial Metric Low Estimate High Estimate
Annual Plasma Collection 200,000 liters 400,000 liters
(Liters)
Revenue Per Liter of Plasma $200 $500
Total Revenue $40,000,000 $200,000,000
Cost Per Donation $72 $196
Total Donations Required 285,714 571,429
Total Annual Operating Costs $38,285,576 $76,285,576
Initial Equipment Investment $32,600 $112,500
Annual Maintenance Costs $1,500 $6,000
Total Costs (Including $38,319,676 $76,404,076
Equipment)
Annual Profit $1,680,324 $123,595,924
Plasma Required for 1g IVIG 2 - 4 liters N/A
Key Financial Insights:
• Scalability: Potential for increasing profits as plasma collection scales.
• Profit Margins: Profitable at both low and high revenue estimates.
• Capital Investment: Manageable initial investment with high returns.
